StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.09+0.07 (+2.32%)

Close on Nov 18, 2026Market cap $72.48MP/E –Yield –

Coya Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Coya Therapeutics's total assets was $39.32M at Sep 30, 2026. For fiscal 2025 it was $49.95M, up 12.6% from the year before. The highest annual figure on record is $49.95M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$49.95M+12.6%
FY2024Dec 31, 2024$44.35M+7.5%
FY2023Dec 31, 2023$41.26M+391.5%
FY2022Dec 31, 2022$8.40M+75.2%
FY2021Dec 31, 2021$4.79M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$39.32M+22.7%
Q2 FY2026Jun 30, 2026$47.31M+41.4%
Q1 FY2026Mar 31, 2026$53.27M+38.7%
Q4 FY2025Dec 31, 2025$49.95M+12.6%
Q3 FY2025Sep 30, 2025$32.04M-9.9%
Q2 FY2025Jun 30, 2025$33.45M-16.2%
Q1 FY2025Mar 31, 2025$38.40M+2.7%
Q4 FY2024Dec 31, 2024$44.35M+7.5%
Q3 FY2024Sep 30, 2024$35.55M+198.9%
Q2 FY2024Jun 30, 2024$39.94M+176.0%
Q1 FY2024Mar 31, 2024$37.39M+114.7%
Q4 FY2023Dec 31, 2023$41.26M+391.5%
Q3 FY2023Sep 30, 2023$11.90M+148.2%
Q2 FY2023Jun 30, 2023$14.47M–
Q1 FY2023Mar 31, 2023$17.42M–
Q4 FY2022Dec 31, 2022$8.40M–
Q4 FY2021Dec 31, 2021$4.79M–

More Coya Therapeutics figures

See a number that looks wrong?